U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

RDInvesting Provides Stocks Research on Amarin and MEI Pharma

Continue Reading

Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High

RDInvesting Provides Stocks Research on Seattle Genetics and Theravance

Continue Reading

Shares of Smartphone Makers Fall as Smartphone Shipments Projected to Experience an Annual Growth Slowdown

RDInvesting Provides Stock Research on Apple and Nokia

Continue Reading

Freddie Mac and Fannie Mae Surging in 2013 as U.S. Housing Market Continues to Improve

RDInvesting Provides Stock Research on Freddie Mac and Fannie Mae

Continue Reading

Mortgage Insurance Industry Benefitting From a Steadily Improving Housing Market in 2013

RDInvesting Provides Stock Research on MGIC Investment and Radian Group

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

RDInvesting Provides Stocks Research on Cerus and Curis

Continue Reading

Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High

RDInvesting Provides Stocks Research on Coronado Biosciences and Clovis Oncology

Continue Reading

Gaming Stocks on the Rise as Major Gambling States — Nevada and New Jersey — Legalize Internet Gambling

RDInvesting Provides Stock Research on Boyd Gaming and International Game Technology

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

RDInvesting Provides Stocks Research on Neostem and Hemispherx BioPharma

Continue Reading

Shares of Zynga and Glu Mobile on the Upswing as Nevada and New Jersey Legalize Online Gambling

RDInvesting Provides Stock Research on Zynga and Glu Mobile

Continue Reading